Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Jan 29, 2016 11:43am
243 Views
Post# 24505708

RE:RE:Zika Virus -- possible indication??

RE:RE:Zika Virus -- possible indication??Bob and Sah1, I would speculate that the answer is NO unless you are talking about protecting the transfusion blood supply from the Zika virus. But using PLI tech to cure people who already have the virus in their system - I an pretty sure (IMHO) that is not something PLI can do. If it could clean all of a particular virus from a persons circulatory system the n PLI would have a blockbuster cure for all viral diseases. clearly that is not happening here. They can clear (protect) a transfusion but not the entire circulatory system in vivo.

Even with the great Panamure Gordon update and all the recent insider buying we are still subject to the biotech indexes. While we are positive at 11 cents (unlike the IBB down about 0.5%) but at this plateau we are now moving more or less in synch with the index. Nevertheless the future looks very rosy.

glta
Stockman6767

Bullboard Posts